Episode Summary
Executive Summary: Michael Kratsios argues the administration is not anti-science but anti-“bad incentives,” claiming U.S. science has become politicized and inefficient. He outlines a “New Golden Age” strategy: refocus federal funding on basic research, reward scientists over institutions, run funding experiments, use AI to accelerate discovery, and prioritize major national projects in space, quantum, nuclear, fusion, and bio to regain U.S. leadership over China.
Main Topics: Administration stance on science and politicization (Priority: 5/5): Kratsios rejects the claim that the administration is anti-science, saying it wants to revive “gold standard” inquiry and remove politics, especially what he sees as DEI-driven grantmaking and COVID-era dogma. Science funding reform and ROI (Priority: 5/5): He argues federal science spending has become less effective, proposing meta-science experiments, different grant durations, and mechanisms like “golden tickets” to improve breakthroughs per dollar. Basic research versus applied/commercial research (Priority: 4/5): The discussion emphasizes that government should primarily fund early-stage, pre-competitive research where private capital has weak incentives, while industry can handle more applied AI and commercialization work. Big national missions and strategic priorities (Priority: 5/5): Kratsios defends targeted national bets—moon return, nuclear in space, quantum computing, fusion, and the Genesis Mission—as modern equivalents of Apollo and Manhattan-style projects. U.S.-China scientific competition (Priority: 5/5): The conversation frames scientific leadership as central to economic and national security, with China seen as a serious competitor in publication volume, industrial policy, and strategic technology supply chains. Universities, alternative research institutions, and talent pipelines (Priority: 4/5): He argues funding should follow great scientists wherever they are—universities, labs, nonprofits, or garages—and criticizes the weakening of STEM pipelines, young researcher compensation, and talent retention. COVID, trust, and public perception of science (Priority: 4/5): A recurring theme is that public trust in science was damaged during COVID by coercive messaging and the treatment of dissent as anti-science, which he says created lasting skepticism.
Key Arguments: The administration is not anti-science; it claims to be pro-science and pro-discovery, illustrated by the “Science a New Golden Age” report. Science has been politicized over the past 15–20 years, and COVID intensified a culture where questioning official narratives was treated as anti-science. Federal science spending has risen substantially, but outcomes have not risen proportionally, implying a decline in ROI and a need to redesign funding mechanisms. Government should focus on basic, early-stage research that private industry will not fund, rather than duplicating work already incentivized by the market. Funding should be more flexible: different grant lengths, portable fellowships, more support for unconventional ideas, and experiments like reviewer “golden tickets.” The U.S. should support scientists wherever they are, not just at universities, and should reward individuals and high-potential young researchers more directly. China is a major competitor because it treats science and technology as foundational to national power and executes long-horizon strategic industrial policy. AI should be used as a tool to accelerate scientific discovery across disciplines, not as a substitute for funding basic science. The U.S. should pursue large, mission-driven projects—space, quantum, fusion, nuclear, bio—while preserving the decentralized, competitive innovation ecosystem. The U.S. needs a stronger STEM pipeline and better retention of foreign-trained talent, while also rebuilding domestic enthusiasm for scientific careers.
Data Points: Nature reader poll support for Kamala Harris: 86% - Cited to show scientists’ political alignment and perception gap with the administration. Nature reader poll support for Donald Trump: 6% - Used to highlight how unpopular Trump is among surveyed scientists. U.S. science and tech funding cited as annual government spending: $200 billion per year - Used to argue government should ask whether spending is allocated in the smartest way. NSF annual basic research budget: $8–9 billion per year - Described as the premier funder of extramural basic research, largely to universities. Share of NSF grants allegedly tied to DEI-related science during Biden: 25% - Cited as a Senate analysis claim to argue politicization of grantmaking. Estimated annual NSF DEI-related funding: About $2 billion per year; roughly $8 billion over four years - Derived from the 25% share claim applied to a four-year period. Unspent funds disrupted/frozen/terminated in 2025: $3 billion - Mentioned as active grants affected by administrative action. NIH funding in 1998: $14 billion - Used to illustrate growth in research funding over time. NIH funding in 2003: $27 billion - Part of the funding trend discussion. NIH funding in 2024: $47 billion - Used to argue funding has more than tripled since 1998. Efficiency decline in outcomes per dollar: Roughly 80-fold since 1950 - Referenced as “Eroom’s Law” to claim research efficiency has worsened dramatically. Efficiency halving interval: Every 9 years - Claim that outcomes per research dollar roughly halve on that cadence. U.S. government share of RD in 1945 era: About 70% government / 30% private sector - Used to contrast the postwar research system with today’s. Current RD funding split: About 30% federal / 70% private sector - Shown as evidence that the research ecosystem has shifted over decades. China spending growth on RD: $33 billion in 2000 to $670 billion in 2021 - Used to emphasize China’s rapid rise in science and technology investment. China RD growth multiple: 19x - Derived from the 2000-to-2021 spending increase. US-born PhD share in computer science decades ago: 70% American / 30% foreign - Cited to show the historical domestic dominance in STEM PhDs. Current US-born PhD share in computer science: Inverted from historical pattern - Used to argue the U.S. STEM pipeline is now heavily foreign-born. Young STEM fellowship count at NSF: Roughly 2,600 fellowships - Refers to flagship GRFP awards for aspiring PhDs. Median age of an NIH intramural researcher: 71 years old - Cited as evidence of aging research institutions and need for younger scientists. Fusion target: 2035 - Administration’s stated goal for fusion deployment. Nuclear reactor in space target: 2028 - Referenced as a bold national mission. Moon mission target for boots on the moon: 2028 - Administration goal for returning Americans to the moon. Moon base target: 2030 - Referenced as the timeline for initial moon base elements. Scientifically relevant quantum computer target: 2028 - National quantum initiative goal directed by executive order. Global cooking fuel users: About 2 billion people - Used to argue cleaner fossil fuels and energy access matter for poverty reduction. Deaths from dirty cooking fuels: Roughly 3 million annually - Used to support the case for practical energy solutions.
Pivotal Quotes: "I think the scientific community has lost its way over the last few decades." — Michael Kratsios: Explaining why he believes science became politicized and less self-critical. "The thing that is not true, and what the data does not support, is that it is a climate emergency." — Michael Kratsios: Framing the administration’s view on climate change and why funding is being redirected. "We want to essentially double the scientific output of the United States by applying AI to our hardest scientific challenges and endeavors." — Michael Kratsios: Describing the Genesis Mission as the administration’s flagship science initiative.
Implications: The transcript signals a major policy shift toward mission-driven, efficiency-focused science funding, reduced deference to universities and orthodoxy, and heavier emphasis on strategic technologies. For researchers, funding may increasingly reward boldness, speed, and national priorities over legacy grant norms.
About All-In with Chamath Jason Sacks And Friedberg
Industry veterans, degenerate gamblers & besties Chamath Palihapitiya, Jason Calacanis, David Sacks & David Friedberg cover all things economic, tech, political, social & poker.
View all episodes from All-In with Chamath Jason Sacks And Friedberg